Cipla has launched Afrezza, an inhaled rapid-acting insulin for adults with diabetes, after CDSCO approval, and plans an awareness drive on insulin adherence
Source :- Companies Read More
August 22, 2026
Cipla rolls out Afrezza inhaled insulin in India after CDSCO approval
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
